1.New inhibitors targeting bacterial RNA polymerase.
Journal of Zhejiang University. Medical sciences 2019;48(1):44-49
Rifamycins, a group of bacterial RNA polymerase inhibitors, are the firstline antimicrobial drugs to treat tuberculosis. In light of the emergence of rifamycinresistant bacteria, development of new RNA polymerase inhibitors that kill rifamycinresistant bacteria with high bioavailability is urgent. Structural analysis of bacterial RNA polymerase in complex with inhibitors by crystallography and cryo-EM indicates that RNA polymerase inhibitors function through five distinct molecular mechanisms:inhibition of the extension of short RNA; competition with substrates; inhibition of the conformational change of the'bridge helix'; inhibition of clamp opening;inhibition of clamp closure. This article reviews the research progress of these five groups of RNA polymerase inhibitors to provide references for the modification of existing RNA polymerase inhibitors and the discovery of new RNA polymerase inhibitors.
Antitubercular Agents
;
therapeutic use
;
Bacteria
;
drug effects
;
enzymology
;
DNA-Directed RNA Polymerases
;
metabolism
;
Drug Discovery
;
trends
;
Drug Resistance, Bacterial
;
Enzyme Activation
;
drug effects
;
Enzyme Inhibitors
;
pharmacology
;
Humans
;
RNA, Bacterial
;
Tuberculosis
;
drug therapy
;
enzymology
2.ToxR Is Required for Biofilm Formation and Motility of Vibrio Parahaemolyticus.
Long CHEN ; Yue QIU ; Hao TANG ; Ling Fei HU ; Wen Hui YANG ; Xiao Jue ZHU ; Xin Xiang HUANG ; Tang WANG ; Yi Quan ZHANG
Biomedical and Environmental Sciences 2018;31(11):848-850
Bacterial Proteins
;
genetics
;
metabolism
;
Biofilms
;
DNA-Binding Proteins
;
genetics
;
metabolism
;
Flagella
;
genetics
;
metabolism
;
Gene Expression Regulation, Bacterial
;
Transcription Factors
;
genetics
;
metabolism
;
Vibrio parahaemolyticus
;
cytology
;
genetics
;
growth & development
;
physiology
3.Antibacterial and Pharmacological Evaluation of Fluoroquinolones: A Chemoinformatics Approach.
Damini SOOD ; Neeraj KUMAR ; Aarushi SINGH ; Meena Kishore SAKHARKAR ; Vartika TOMAR ; Ramesh CHANDRA
Genomics & Informatics 2018;16(3):44-51
Fluoroquinolone (FQ) antibiotics are an important class of synthetic antibacterial agents. These are the most extensively used drugs for treating bacterial infections in the field of both human and veterinary medicine. Herein, the antibacterial and pharmacological properties of four fluoroquinolones: lomefloxacin, norfloxacin, ciprofloxacin, and ofloxacin have been studied. The objective of this study was to analyze the antibacterial characteristics of the different fluoroquinolones. Also, the pharmacological properties of the compounds including the Lipinski rule of five, absorption, distribution, metabolism, and excretion, LD50, drug likeliness, and toxicity were evaluated. We found that among all four FQ molecules, ofloxacin showed the highest antibacterial activity through in silico assays with a strong interaction (−38.52 kJ/mol) with the antibacterial target protein (topoisomerase-II DNA gyrase enzyme). The pharmacological and pharmacokinetic analysis also showed that the compounds ciprofloxacin, ofloxacin, lomefloxacin and norfloxacin have good pharmacological properties. Notably, ofloxacin was found to possess an IGC50 (concentration needed to inhibit 50% growth) value of 0.286 μg/L against the Tetrahymena pyriformis protozoa. It also tested negative for the Ames toxicity test, showing its non-carcinogenic character.
Absorption
;
Anti-Bacterial Agents
;
Bacterial Infections
;
Ciprofloxacin
;
Computer Simulation
;
DNA Gyrase
;
Fluoroquinolones*
;
Humans
;
Lethal Dose 50
;
Metabolism
;
Norfloxacin
;
Ofloxacin
;
Tetrahymena pyriformis
;
Toxicity Tests
;
Veterinary Medicine
4.Change of bacterial community structure during cellulose degradation by the microbial consortium.
Shiqi AI ; Yiquan ZHAO ; Zhiyuan SUN ; Yamei GAO ; Lei YAN ; Hongzhi TANG ; Weidong WANG
Chinese Journal of Biotechnology 2018;34(11):1794-1808
In order to clarify dynamic change of microbial community composition and to identify key functional bacteria in the cellulose degradation consortium, we studied several aspects of the biodegradation of filter papers and rice straws by the microbial consortium, the change of substrate degradation, microbial biomass and pH of fermentation broth. We extracted total DNA of the microbial consortium in different degradation stages for high-throughput sequencing of amplicons of bacterial 16 S rRNA genes. Based on the decomposition characteristics test, we defined the 12th, 72nd and 168th hours after inoculation as the initial stage, peak stage and end stage of degradation, respectively. The microbial consortium was mainly composed of 1 phylum, 2 classes, 2 orders, 7 families and 11 genera. With cellulose degradation, bacteria in the consortium showed different growth trends. The relative abundance of Brevibacillus and Caloramator decreased gradually. The relative abundance of Clostridium, Bacillus, Geobacillus and Cohnella increased gradually. The relative abundance of Ureibacillus, Tissierella, Epulopiscium was the highest in peak stage. The relative abundance of Paenibacillus and Ruminococcus did not change obviously in each stage. Above-mentioned 11 main genera all belonged to Firmicutes, which are thermophilic, broad pH adaptable and cellulose or hemicellulose degradable. During cellulose degradation by the microbial consortium, aerobic bacteria were dominant functional bacteria in the initial stage. However, the relative abundance of anaerobic bacteria increased gradually in middle and end stage, and replaced aerobic bacteria to become main bacteria to degrade cellulose.
Bacteria
;
classification
;
metabolism
;
Biodegradation, Environmental
;
Cellulose
;
metabolism
;
DNA, Bacterial
;
genetics
;
Microbial Consortia
;
RNA, Ribosomal, 16S
;
genetics
5.First Case Report of Bacteremia Due to Catabacter hongkongensis in a Korean Patient.
Yong Jun CHOI ; Eun Jeong WON ; Soo Hyun KIM ; Myung Geun SHIN ; Jong Hee SHIN ; Soon Pal SUH
Annals of Laboratory Medicine 2017;37(1):84-87
No abstract available.
Aged
;
Anti-Bacterial Agents/pharmacology/therapeutic use
;
Cefotaxime/analogs & derivatives/therapeutic use
;
Cholangiopancreatography, Endoscopic Retrograde
;
Gallstones/surgery
;
Gram-Negative Anaerobic Bacteria/drug effects/genetics/*isolation & purification
;
Gram-Negative Bacterial Infections/*diagnosis/drug therapy/microbiology
;
Humans
;
Male
;
Metronidazole/therapeutic use
;
Microbial Sensitivity Tests
;
RNA, Ribosomal, 16S/chemistry/genetics/metabolism
;
Sequence Analysis, DNA
;
Tomography, X-Ray Computed
6.Susceptibility of Ceftolozane-Tazobactam and Ceftazidime-Avibactam Against a Collection of β-Lactam-Resistant Gram-Negative Bacteria.
Mark D GONZALEZ ; Allison R MCMULLEN ; Meghan A WALLACE ; Matthew P CROTTY ; David J RITCHIE ; Carey Ann D BURNHAM
Annals of Laboratory Medicine 2017;37(2):174-176
No abstract available.
Anti-Bacterial Agents/*pharmacology
;
Azabicyclo Compounds/*pharmacology
;
Bacterial Proteins/genetics
;
Ceftazidime/*pharmacology
;
Cephalosporins/*pharmacology
;
DNA, Bacterial/genetics/metabolism
;
Drug Resistance, Bacterial/*drug effects
;
Gram-Negative Bacteria/drug effects/*isolation & purification
;
Humans
;
Microbial Sensitivity Tests
;
Penicillanic Acid/*analogs & derivatives/pharmacology
;
Pseudomonas aeruginosa/drug effects/isolation & purification
;
Real-Time Polymerase Chain Reaction
7.Structural insights into glutathione-mediated activation of the master regulator PrfA in Listeria monocytogenes.
Yong WANG ; Han FENG ; Yalan ZHU ; Pu GAO
Protein & Cell 2017;8(4):308-312
Bacterial Proteins
;
chemistry
;
genetics
;
metabolism
;
DNA, Bacterial
;
chemistry
;
genetics
;
metabolism
;
Gene Expression Regulation, Bacterial
;
physiology
;
Glutathione
;
metabolism
;
Listeria monocytogenes
;
chemistry
;
genetics
;
metabolism
;
Peptide Termination Factors
;
chemistry
;
genetics
;
metabolism
8.Prevalence of Major Methicillin-Resistant Staphylococcus aureus Clones in Korea Between 2001 and 2008.
Gi Su KANG ; Yung Hee JUNG ; Hwa Su KIM ; Yeong Seon LEE ; Chan PARK ; Kwang Jun LEE ; Jeong Ok CHA
Annals of Laboratory Medicine 2016;36(6):536-541
BACKGROUND: Methicillin-resistant Staphylococcus aureus (MRSA) are important pathogens causing nosocomial infections in Korean hospitals. This study aimed to investigate the epidemiological and genetic diversity of clinical S. aureus isolates in healthcare settings from 2001 to 2008. METHODS: Samples and data were obtained from 986 individuals as part of the National Antimicrobial Surveillance Project, involving 10 regions nationwide. Molecular typing studies, including multilocus sequence typing (MLST) and staphylococcal cassette chromosome mec (SCCmec) typing were performed, and a representative clone of Korean MRSA was classified by combinational grouping using a DiversiLab (DL; bioMérieux, France) repetitive element polymerase chain reaction (rep-PCR) system. RESULTS: Nine Korean MRSA clones (KMRSA-1 to -9) were identified by analysis of genetic backgrounds and molecular characteristics. KMRSA-1 to -3, expressing clonal complex (CC) 5 (carrying SCCmec II), CC8 (carrying SCCmec III), and CC72 (carrying SCCmec IV) were spread nationwide. In contrast, KMRSA-6 was highly prevalent in Gyeongsangnam-do, and KMRSA-4 was highly prevalent in Jeollanam-do and Jeollabuk-do. CONCLUSIONS: Epidemic KMRSA clones were genetically similar to major clones identified from the USA, with the exception of KMRSA-2, which had the SCCmec III type. Our results provide important insights into the distribution and molecular genetics of MRSA strains in Korea and may aid in the monitoring of MRSA spread throughout the country.
Bacterial Proteins/genetics
;
DNA, Bacterial/genetics/metabolism
;
Electrophoresis, Gel, Pulsed-Field
;
Hospitals
;
Humans
;
Methicillin-Resistant Staphylococcus aureus/*genetics/isolation & purification
;
Multilocus Sequence Typing
;
Multiplex Polymerase Chain Reaction
;
Prevalence
;
Republic of Korea/epidemiology
;
Staphylococcal Infections/diagnosis/*epidemiology/microbiology
9.First Case of Human Brucellosis Caused by Brucella melitensis in Korea.
Hyeong Nyeon KIM ; Mina HUR ; Hee Won MOON ; Hee Sook SHIM ; Hanah KIM ; Misuk JI ; Yeo Min YUN ; Sung Yong KIM ; Jihye UM ; Yeong Seon LEE ; Seon Do HWANG
Annals of Laboratory Medicine 2016;36(4):390-392
No abstract available.
Adult
;
Anti-Bacterial Agents/therapeutic use
;
Bacterial Proteins/chemistry/genetics/metabolism
;
Brucella melitensis/classification/genetics/*isolation & purification
;
Brucellosis/*diagnosis/drug therapy/microbiology
;
Doxycycline/therapeutic use
;
Humans
;
Magnetic Resonance Imaging
;
Male
;
Phylogeny
;
Polymerase Chain Reaction
;
Republic of Korea
;
Rifampin/therapeutic use
;
Sequence Analysis, DNA
;
Spondylitis/diagnostic imaging
10.Prediction of Putative Resistance Islands in a Carbapenem-Resistant Acinetobacter baumannii Global Clone 2 Clinical Isolate.
Yangsoon LEE ; Roshan D'SOUZA ; Dongeun YONG ; Kyungwon LEE
Annals of Laboratory Medicine 2016;36(4):320-324
BACKGROUND: We investigated the whole genome sequence (WGS) of a carbapenem-resistant Acinetobacter baumannii isolate belonging to the global clone 2 (GC2) and predicted resistance islands using a software tool. METHODS: A. baumannii strain YU-R612 was isolated from the sputum of a 61-yr-old man with sepsis. The WGS of the YU-R612 strain was obtained by using the PacBio RS II Sequencing System (Pacific Biosciences Inc., USA). Antimicrobial resistance genes and resistance islands were analyzed by using ResFinder and Genomic Island Prediction software (GIPSy), respectively. RESULTS: The YU-R612 genome consisted of a circular chromosome (ca. 4,075 kb) and two plasmids (ca. 74 kb and 5 kb). Its sequence type (ST) under the Oxford scheme was ST191, consistent with assignment to GC2. ResFinder analysis showed that YU-R612 possessed the following resistance genes: four β-lactamase genes bla(ADC-30), bla(OXA-66), bla(OXA-23), and bla(TEM-1); armA, aadA1, and aacA4 as aminoglycoside resistance-encoding genes; aac(6')Ib-cr for fluoroquinolone resistance; msr(E) for macrolide, lincosamide, and streptogramin B resistance; catB8 for phenicol resistance; and sul1 for sulfonamide resistance. By GIPSy analysis, six putative resistant islands (PRIs) were determined on the YU-R612 chromosome. Among them, PRI1 possessed two copies of Tn2009 carrying bla(OXA-23), and PRI5 carried two copies of a class I integron carrying sul1 and armA genes. CONCLUSIONS: By prediction of resistance islands in the carbapenem-resistant A. baumannii YU-R612 GC2 strain isolated in Korea, PRIs were detected on the chromosome that possessed Tn2009 and class I integrons. The prediction of resistance islands using software tools was useful for analysis of the WGS.
Acinetobacter Infections/*drug therapy/microbiology
;
Acinetobacter baumannii/drug effects/*genetics/isolation & purification
;
Anti-Bacterial Agents/pharmacology/*therapeutic use
;
Bacterial Proteins/genetics
;
Carbapenems/*therapeutic use
;
DNA, Bacterial/chemistry/*genetics/metabolism
;
Drug Resistance, Bacterial
;
Genomic Islands/genetics
;
Humans
;
Microbial Sensitivity Tests
;
Multilocus Sequence Typing
;
Plasmids/genetics/metabolism
;
Polymerase Chain Reaction
;
Sequence Analysis, DNA

Result Analysis
Print
Save
E-mail